Most screening readouts are snapshots. An endpoint measurement can obscure differences in association rate and dissociation ...
New research reveals how MRSA exploits the kidney’s hyperosmotic inner medulla to evade immune defenses, establish a persistent reservoir, and spread.
AI-guided structural modeling and proteomics identified molecular glues that degrade VAV1, a potential target in blood cancers and autoimmune diseases.
Merck acquires global rights to SciBrunch Therapeutics’ SPR2015, a preclinical oral KRAS G12D inhibitor, in a deal worth up ...